Emergence of Resistance to Quinolones and β-Lactam Antibiotics in Enteroaggregative and Enterotoxigenic Escherichia coli Causing Traveler's Diarrhea

被引：40
作者：
Guiral, Elisabet [1 ]
Goncalves Quiles, Milene [1 ]
Munoz, Laura [1 ]
Moreno-Morales, Javier [1 ]
Alejo-Cancho, Izaskun [2 ,3 ]
Salvador, Pilar [2 ]
Alvarez-Martinez, Miriam J. [1 ,2 ]
Marco, Francesc [1 ,2 ]
Vila, Jordi [1 ,2 ]
机构：
[1] Inst Global Hlth Barcelona, Barcelona, Spain
[2] Univ Barcelona, Dept Clin Microbiol, Hosp Clin, Sch Med, Barcelona, Spain
[3] Hosp Univ Cruces, Serv Microbiol, Baracaldo, Bizkaia, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2019年 / 63卷 / 02期
关键词：
cephalosporin; enteroaggregative E. coli; enterotoxigenic E. coli; quinolones; resistance; traveler's diarrhea; IN-VITRO ACTIVITY; ANTIMICROBIAL RESISTANCE; MULTIPLEX PCR; YOUNG-CHILDREN; SPECTRUM; MULTICENTER; RIFAXIMIN; ETIOLOGY; GENES; ENTEROBACTERIACEAE;
D O I：
10.1128/AAC.01745-18
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The objective of this study was to assess the antimicrobial resistance of enteroaggregative Escherichia coli (EAEC) and enterotoxigenic E. coli (ETEC) strains causing traveler's diarrhea (TD) and to investigate the molecular characterization of antimicrobial resistance genes to third-generation cephalosporins, cephamycins, and quinolones. Overall, 39 EAEC and 43 ETEC clinical isolates were studied. The susceptibilities of EAEC and ETEC against ampicillin, amoxicillin-clavulanic acid, cefotaxime, imipenem, chloramphenicol, tetracycline, co-trimoxazole, nalidixic acid, ciprofloxacin, azithromycin, and rifaximin were determined. All genes encoding resistance determinants were detected by PCR or PCR plus DNA sequencing. The epidemiology of selected EAEC and ETEC strains was studied using multilocus sequence typing (MLST). The resistance to quinolones of EAEC and ETEC strains causing TD has significantly increased over the last decades, and high percentages have been found especially in patients traveling to India and sub-Saharan Africa. Sequence type 38 (ST38) and ST131, carrying the bla(CTX-M-15) and bla(CTX-M-27) genes, respectively, are highly prevalent among extended-spectrum beta-lactamase (ESBL)-producing EAEC and ETEC strains. The cephamycinase ACT-20 is described in the present study for the first time in EAEC and ETEC strains causing TD in patients who had traveled to Central America. The percentages of resistance to azithromycin in EAEC and ETEC isolates from patients to Southeast Asia/India and Africa are above 25%. Meanwhile, rifaximin is still active against EAEC and ETEC, with the prevalence of resistant strains not being high. In conclusion, fluoroquinolones should no longer be considered the drugs of choice for the prevention or treatment in TD for travelers traveling to India and Africa. Azithromycin and rifaximin are still a good alternative to treat TD caused by EAEC or ETEC.
引用
收藏
页数：9
相关论文
共 65 条
[41]   Diarrhoeagenic Escherichia coli in mother-child Pairs in Ile-Ife, South Western Nigeria [J].
Odetoyin, Babatunde W. ;
Hofmann, Jennifer ;
Aboderin, Aaron O. ;
Okeke, Iruka N. .
BMC INFECTIOUS DISEASES, 2016, 16
[42]   Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages [J].
Okeke, Iruka N. ;
Wallace-Gadsden, Faith ;
Simons, Hannah R. ;
Matthews, Nicholas ;
Labar, Amy S. ;
Hwang, Jennifer ;
Wain, John .
PLOS ONE, 2010, 5 (11)
[43]   Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli [J].
Ortega, Adriana ;
Oteo, Jesus ;
Aranzamendi-Zaldumbide, Maitane ;
Bartolome, Rosa M. ;
Bou, German ;
Cercenado, Emilia ;
Carmen Conejo, M. ;
Jose Gonzalez-Lopez, Juan ;
Marin, Mercedes ;
Martinez-Martinez, Luis ;
Merino, Maria ;
Navarro, Ferran ;
Oliver, Antonio ;
Pascual, Alvaro ;
Rivera, Alba ;
Rodriguez-Bano, Jesus ;
Weber, Irene ;
Aracil, Belen ;
Campos, Jose .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) :3576-3581
[44]   Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme [J].
Park, Chi Hye ;
Robicsek, Ari ;
Jacoby, George A. ;
Sahm, Daniel ;
Hooper, David C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) :3953-3955
[45]  
Pazhani GP, 2011, INDIAN J MED RES, V134, P214
[46]   Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance [J].
Pitout, Johann D. D. .
FRONTIERS IN MICROBIOLOGY, 2012, 3
[47]   Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report [J].
Riddle, Mark S. ;
Connor, Bradley A. ;
Beeching, Nicholas J. ;
DuPont, Herbert L. ;
Hamer, Davidson H. ;
Kozarsky, Phyllis ;
Libman, Michael ;
Steffen, Robert ;
Taylor, David ;
Tribble, David R. ;
Vila, Jordi ;
Zanger, Philipp ;
Ericsson, Charles D. .
JOURNAL OF TRAVEL MEDICINE, 2017, 24 :S63-S80
[48]   In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea [J].
Ruiz, Joaquim ;
Mensa, Laura ;
O'Callaghan, Cristina ;
Pons, Maria J. ;
Gonzalez, Ana ;
Vila, Jordi ;
Gascon, Joaquim .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 59 (04) :473-475
[49]   Validation of a PCR technique for the detection of enteroagreggative Escherichia coli causing traveler's diarrhea [J].
Ruiz-Blázquez, J ;
Vargas, M ;
Nataro, JP ;
Vila, J ;
Brustenga, JGI .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2005, 23 (08) :479-481
[50]   In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea [J].
Sierra, JM ;
Ruiz, J ;
Navia, MM ;
Vargas, M ;
Gascon, J ;
Vila, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :643-644
1234567